CLINICAL OUTCOMES OF DIFFERENT CONTEMPORARY DRUG-ELUTING STENTS IN PATIENTS WITH AND WITHOUT DIABETES MELLITUS: MULTIGROUP PROPENSITY-SCORE ANALYSIS USING DATA FROM THE STENT-SPECIFIC, MULTI-CENTER, PROSPECTIVE REGISTRIES

Whether the diabetic status differentially affects the relative clinical outcomes with different types of drug-eluting stents (DES) has been debated. From prospective registries, 11,428 of non-diabetics and 5,756 of diabetics were analysed; 5,023 cobalt-chromium everolimus-eluting stent (CoCr-EES